Volume 13, Number 7—July 2007
Research
Ongoing Genome Reduction in Mycobacterium ulcerans
Table
RD | Deletion no. | Plasmid no. | Origin | Size of deletion, kb | No. CDSs and pseudogenes |
---|---|---|---|---|---|
1 | 1 | p8 | SU/FG | 11.1 | 14 |
2 | 2 | p34 | SU/FG | 6.6–6.8 | 4 |
3 | 3A | p58 | AU1/AU2 | 3.5 | 5 |
3B | p58 | SU/FG | 3.8 | 6 | |
4 | 4 | p60, p61 | SU/FG | 1.8–2.4 | 2 |
5 | 5 | p88, p153, p360 | ME1/ME2 | 27.1–27.4 | 23 |
6 | 6 | p92 | JP/CH/ME1/ME2 | 19.7 | 24 |
7 | 7 | p100 | SU/FG | 15.3 | 13 |
8 | 8 | p124, p291 | ME1/ME2 | 52.8–53.1 | 50 |
9 | 9A | p144 | JP/CH | 18.1 | 15 |
9B | p144 | SU/FG | 25.4 | 20 | |
10 | 10 | p170 | ME1/ME2 | 8.2–8.7 | 10 |
11 | 11 | p305 | JP/CH | 4.6 | 7 |
12 | 12A | p315 | JP/CH | 53.1 | 50 |
12B | p315 | SU/FG | 35.4–35.5 | 32 |
*RD, region of difference; CDSs, coding sequences; SU, Suriname; FG, French Guiana; AU, Australia; ME, Mexico; JP, Japan; CH, China.
Page created: June 23, 2010
Page updated: June 23, 2010
Page reviewed: June 23, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.